Thus, the major mechanisms by which type I NKT cells protect involve several pathways, production of IFN-γ, activation of DCs to make IL-12 and also be more effective antigen-presenting cells, and then downstream activation of NK cells and CD8+ T cells that also make IFN-γ and mediate tumor lysis. The gene discussed is CD8A; the disease is neoplasm.